Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
KTP3001 ExKine™ Nuclear and Cytoplasmic Protein Extraction Kit miR‑30a‑5p induces the adipogenic differentiation of bone marrow mesenchymal stem cells by targeting FAM13A/Wnt/β‑catenin signaling in aplastic anemia(KTP3001-2.1) 2.1 Mol Med Rep
KTD3001 Protein Quantification Kit (BCA Assay) miR‑30a‑5p induces the adipogenic differentiation of bone marrow mesenchymal stem cells by targeting FAM13A/Wnt/β‑catenin signaling in aplastic anemia(KTD3001-2.1) 2.1 Mol Med Rep
A23230 Dylight 488, Rabbit Anti-Goat IgG ILT4 inhibition prevents TAM-and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR …(A23230-8.579) 8.579 Theranostics
A23240 Dylight 488, Goat Anti-Rat IgG ILT4 inhibition prevents TAM-and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR …(A23240-8.579) 8.579 Theranostics
A23430 Dylight 594, Rabbit Anti-Goat IgG ILT4 inhibition prevents TAM-and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR …(A23430-8.579) 8.579 Theranostics
BMD0063 DAPI ILT4 inhibition prevents TAM-and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR …(BMD0063-8.579) 8.579 Theranostics
A23410 Dylight 594, Goat Anti-Mouse IgG ILT4 inhibition prevents TAM-and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR …(A23410-8.579) 8.579 Theranostics
A22120 FITC, Goat Anti-Rabbit IgG Pathological Features of Echovirus-11-Associated Brain Damage in Mice Based on RNA-Seq Analysis(A22120-3.816) 3.816 Viruses. Viruses
A22110 FITC, Goat Anti-Mouse IgG Pathological Features of Echovirus-11-Associated Brain Damage in Mice Based on RNA-Seq Analysis(A22110-3.816) 3.816 Viruses.
KTB1010 CheKine™ Micro Coenzyme Ⅱ NADP(H) Assay Kit Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning(KTB1010-3.647) 3.647 Life Sci